On the antiatherogenity of calcium channel blockers: studies in proliferating vascular smooth muscle cells on age sensitivity, dose dependent inhibitory effect, and time of action

Bilato, 1995, Intercellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor, J. Clin. Invest., 96, 1905, 10.1172/JCI118236 Fujiwara, 1994, Diltiazem inhibits DNA synthesis and Ca2+ uptake induced by insulin, IGF-1 and PDGF in vascular smooth muscle cells, Cardiovasc. Drugs Ther., 8, 861, 10.1007/BF00877405 Gaumond, 1997, Differential signaling pathways in platelet-activating factor-induced proliferation and interleukin-6 production by rat vascular smooth muscle cells, J. Cardiovasc. Pharmacol., 30, 169, 10.1097/00005344-199708000-00004 Kataoka, 1997, Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists, Stroke, 28, 364, 10.1161/01.STR.28.2.364 Katz, 1997, Molecular biology of calcium channels in the cardiovascular system, Am. J. Cardiol., 80, 171 Kimes, 1976, Characterization of two putative smooth muscle cell lines from rat thoracic aorta, Exp. Cell Res., 98, 349, 10.1016/0014-4827(76)90446-8 Knoch, 1963, Isoptin. A clinical study using normal subjects and patients with coronary disease, Med. Klin., 58, 1485 Kuga, 1996, Cell cycle-dependent expression of L- and T-type Ca2+ currents in rat aortic smooth muscle cells in primary culture, Circ. Res., 79, 14, 10.1161/01.RES.79.1.14 Magnier-Gaubil, 1996, Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sacro-endoplasmic reticulum Ca2+ ATPase regulation, J. Biol. Chem., 271, 27788, 10.1074/jbc.271.44.27788 Marche, 1997, Pharmacologic treatment of atherosclerosis beyond lipid-lowering therapy, Int. J. Cardiol., 62, S17, 10.1016/S0167-5273(97)00237-4 Mykkänen, 1993, High plasma insulin level associated with coronary heart disease in the elderly, Am. J. Epidemiol., 137, 1190, 10.1093/oxfordjournals.aje.a116621 Mykkänen, 1994, Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects, Arterioescler. Thromb., 14, 518, 10.1161/01.ATV.14.4.518 Ross, 1993, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, 362, 801, 10.1038/362801a0 Ruiz-Torres, 1999, Age-related loss of proliferative activity of human vascular smooth muscle cells in culture, Mech. Ageing Dev., 110, 49, 10.1016/S0047-6374(99)00042-1 Schachter, 1997, Calcium antagonists and atherosclerosis, Intern. J. Cardiol., 62, S9, 10.1016/S0167-5273(97)00236-2 Stepien, 1998, Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth muscle cell proliferation, J. Cardiovasc. Pharmacol., 31, 786, 10.1097/00005344-199805000-00019 Voisard, 1997, High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis, Coron. Artery Dis., 8, 189, 10.1097/00019501-199703000-00011 Yoo, 1997, Augmented Ca2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats, Atherosclerosis, 131, 167, 10.1016/S0021-9150(97)06098-X